| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000005423 |
| Receipt No. | R000006439 |
| Official scientific title of the study | Examination of effect of yokukansan in prevention of the delirium after the surgical operation. |
| Date of disclosure of the study information | 2011/04/12 |
| Last modified on | 2016/06/01 (Ver. 15) |
| Basic information | ||
| Official scientific title of the study | Examination of effect of yokukansan in prevention of the delirium after the surgical operation. | |
| Title of the study (Brief title) | Examination of effect of yokukansan in prevention of the delirium after the surgical operation. | |
| Region |
|
|
| Condition | ||||
| Condition | Gastrointestinal cancer
Lung cancer |
|||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | We examine the effect of the yokukansan ,which is administered before and after the surgery, in prevention of the delirium after the surgical operation. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Incidence of delirium after the operation
safety |
| Key secondary outcomes | Hospital days after the operation
Severity of symptoms of delirium |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | yokukansan administering group | |
| Interventions/Control_2 | yokukansan non-administering group | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients undergoing elective surgery for gastrointestinal cancer or lung cancer.
2)Patients aged over 70. 3)ECOG Performance status is 0 to 2 4)Patient who is not scheduled to enter ICU after the operation. 5)Major organ function is preserved. 6)Witten informed consent is taken. |
|||
| Key exclusion criteria | 1)Prior therapy with major tranquilizer within the past 6 months.
2)Serious complications due to psychological illness. 3)Uncontrollable heart disease. 4)Chronic renal failure or renal disfunction(Cr>=1.5 mg/dl). 5)Patients judged to be inappropriate by doctor in charge. |
|||
| Target sample size | 220 | |||
| Research contact person | |
| Name of lead principal investigator | Yasushi Rino |
| Organization | Yokohama City University |
| Division name | general surgery |
| Address | 3-9Fukuura,Kanazawa-ku,Yokohama City,236-0004,Japan |
| TEL | 045-787-2645 |
| rino@med.yokohama-cu.ac.jp | |
| Public contact | |
| Name of contact person | Nobuhiro Sugano |
| Organization | Yokohama City University |
| Division name | general surgery |
| Address | 3-9Fukuura,Kanazawa-ku,Yokohama City,236-0004,Japan |
| TEL | 045-261-5656 |
| Homepage URL | |
| suga_p1012@yahoo.co.jp | |
| Sponsor | |
| Institute | Department of surgery,yokohama city university |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 神奈川県立足柄上病院(神奈川県)
国際医療福祉大学 熱海病院(静岡県) 国家公務員共済組合連合会 平塚共済病院(神奈川県) 国家公務員共済組合連合会 南共済病院(神奈川県) 国家公務員共済組合連合会 横須賀共済病院(神奈川県) 総合病院 秦野赤十字病院(神奈川県) 藤沢湘南台病院 (神奈川県) 横浜市立大学附属市民総合医療センター(神奈川県) 横浜市立大学附属病院(神奈川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000006439 |